CT
BNTX icon

Caldwell Trust’s BioNTech BNTX Stock Holding History

Caldwell Trust’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$931 Hold
10
– – ﹤0.01% 795
2026
Q1 		$889 Hold
10
– – ﹤0.01% 774
2025
Q4 		$952 Hold
10
– – ﹤0.01% 743
2025
Q3 		$986 Hold
10
– – ﹤0.01% 737
2025
Q2 		$1.06K Hold
10
– – ﹤0.01% 730
2025
Q1 		$911 Buy
+10
New +$1.12K ﹤0.01% 738

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Caldwell Trust's BNTX Position: Q2 2026 in Review

Caldwell Trust held its BioNTech (BNTX) position steady in Q2 2026 at 10 shares worth $931. The position accounts for ﹤0.01% of the portfolio, ranked #795.

Caldwell Trust first reported a position in BNTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.06K in Q2 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Caldwell Trust held 10 shares of BioNTech worth $931 as of Q2 2026.
  • Caldwell Trust left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up ﹤0.01% of Caldwell Trust's portfolio in Q2 2026, its #795 holding.
  • Caldwell Trust first reported a position in BioNTech in Q1 2025 and has held it in 6 quarters since.
  • Caldwell Trust's BioNTech position peaked at $1.06K in Q2 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.